Tag: CSE:PREV

October 30, 2018

PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to announce that its research team at the University of Queensland,...
October 15, 2018

PreveCeutical to Visit Penta 5 Group’s Packaging Facility for Due Diligence on Proposed Acquisition

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces an update on the Company's due diligence on the Penta 5 group of...
October 3, 2018

PreveCeutical Announces LOI to Acquire Penta 5 Health and Wellness Packaging Companies with Market-Ready Products and Production Facilities

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) (the "Company" or "PreveCeutical"), announces that the Company has entered into a letter of intent dated October 1, 2018...
September 26, 2018

PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into a development...
September 25, 2018

Special Delivery: CBD and Cannabis Delivery Systems

Innovative CBD and cannabis delivery systems are critical to growth in the plant’s medicinal market.
September 4, 2018

PreveCeutical Develops Proprietary Extraction Protocol for Medical Cannabinoids to be Used with the Sol-gel Drug Delivery Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that, during its soluble gel ("Sol-gel") drug delivery research...
August 22, 2018

PreveCeutical Provides Corporate Update

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on the Company's progress in its ongoing corporate...